Ariel Daube

Ariel Daube

Auto-generated profile, based on publicly available information

Ariel Daube

Division of Pediatric Critical Care, New York University Grossman School of Medicine, 424 East 34th Street, New York, NY, 10016, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2020 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
LFLeora R. Feldstein
Leora R. Feldstein
ERErica B. Rose
Erica B. Rose
SHSteven M. Horwitz
Steven M. Horwitz
JCJennifer P. Collins
Jennifer P. Collins
MNMargaret M. Newhams
Margaret M. Newhams
ARAdrienne G. Randolph
Adrienne G. Randolph
Understanding the epidemiology and clinical course of multisystem inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus disease 2019 (Covid-19) is important, given the clinical and public health implications of the syndrome. We conducted targeted surveillance for MIS-C from March 15 to May 20, 2020, in pediatric health centers across the United States. The case definition included six criteria: serious illness leading to hospitalization, an age of less than 21 years, fever that lasted for at least 24 hours, laboratory evidence of inflammation, multisystem organ involvement, and evidence of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on reverse-transcriptase polymerase chain reaction (RT-PCR), antibody testing, or exposure to persons with Covid-19 in the past month. Clinicians abstracted the data onto standardized forms. We report on 186 patients with MIS-C in 26 states. The median age was 8.3 years, 115 patients (62%) were male, 135 (73%) had previously been healthy, 131 (70%) were positive for SARS-CoV-2 by RT-PCR or antibody testing, and 164 (88%) were hospitalized after April 16, 2020. Organ-system involvement included the gastrointestinal system in 171 patients (92%), cardiovascular in 149 (80%), hematologic in 142 (76%), mucocutaneous in 137 (74%), and respiratory in 131 (70%). The median duration of hospitalization was 7 days (interquartile range, 4 to 10); 148 patients (80%) received intensive care, 37 (20%) received mechanical ventilation, 90 (48%) received vasoactive support, and 4 (2%) died. Coronary-artery aneurysms (z scores ≥2.5) were documented in 15 patients (8%), and Kawasaki’s disease–like features were documented in 74 (40%). Most patients (171 [92%]) had elevations in at least four biomarkers indicating inflammation. The use of immunomodulating therapies was common: intravenous immune globulin was used in 144 (77%), glucocorticoids in 91 (49%), and interleukin-6 or 1RA inhibitors in 38 (20%). Multisystem inflammatory syndrome in children associated with SARS-CoV-2 led to serious and life-threatening illness in previously healthy children and adolescents. (Funded by the Centers for Disease Control and Prevention.)

1 May 2021 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
ADAriel Daube
Ariel Daube
SRScott Rickert
Scott Rickert
RMRebecca Pellett Madan
Rebecca Pellett Madan
PKPhilip Kahn
Philip Kahn
JRJoanne Rispoli
Joanne Rispoli
HDHeda Dapul
Heda Dapul

26 January 2021 in Neurology Clinical Practice
Verified
Journal Article
Closed access
PDF file
ADAriel Daube
Ariel Daube
MGMohamed Gaffoor
Mohamed Gaffoor
ZGZhanna Georgievskaya
Zhanna Georgievskaya
JAJeffrey R. Avner
Jeffrey R. Avner
We present the case of a 3-month-old boy who suffered bilateral pneumothoraces secondary to insufflation of oxygen into the endotracheal tube during the apnea test as part of brain death testing. Although rare, awareness of this potential complication of the apnea test is of particular importance in pediatric patients who have narrow endotracheal tubes, as resistance to expiratory flow increases exponentially as lumen diameter decreases.